Negative HER-2 by Immunohistochemistry Correlates Strongly with Negative HER-2 Amplification by Fluorescence In Situ Hybridization in Triple Negative Breast Cancers

被引：0
|
作者：
Xian, R. [1 ]
Raghunath, P. [1 ]
Paul, Z. [1 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
307
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [41] Low Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus
    Rygiel, Agnieszka M.
    Milano, Francesca
    ten Kate, Fiebo J.
    Bergman, Jacques J. G. H. M.
    Krishnadath, Kausillia K.
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [42] Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in-situ-hybridization
    Shanmugalingam, A.
    Hitos, K.
    Pathmanathan, N.
    Edirimmane, S.
    Hughes, M. T.
    Ngui, N. K.
    BREAST, 2023, 68 : S29 - S29
  • [43] Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization
    Isola, J
    Tanner, M
    Forsyth, A
    Cooke, TG
    Watters, AD
    Bartlett, JMS
    CLINICAL CANCER RESEARCH, 2004, 10 (14) : 4793 - 4798
  • [44] Equivocal cases of Her-2 gene amplification detected by fluorescence in situ hybridization.
    Espinoza, FP
    Yang, X
    Reddy, KS
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 76 - 76
  • [45] HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization
    Ross, JS
    Sheehan, C
    HaynerBuchan, AM
    Ambros, RA
    Kallakury, BVS
    Kaufman, R
    Fisher, HAG
    Muraca, PJ
    HUMAN PATHOLOGY, 1997, 28 (07) : 827 - 833
  • [46] Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification
    Lal, P
    Salazar, PA
    Ladanyi, M
    Chen, BY
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (03): : 155 - 159
  • [47] Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer
    Mark, HFL
    Feldman, D
    Das, S
    Kye, H
    Mark, S
    Sun, CL
    Samy, M
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1999, 66 (02) : 170 - 178
  • [48] Fluorescence in situ hybridization for HER-2 amplification in patients with Barrett's esophagus.
    Brankley, SM
    Harwood, AR
    Morrison, LE
    Legator, MS
    Lutzke, LS
    Wang, KK
    Kipp, BR
    Halling, KC
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 688 - 688
  • [49] HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary
    Ross, JS
    Yang, F
    Kallakury, BVS
    Sheehan, CE
    Ambros, RA
    Muraca, PJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (03) : 311 - 316
  • [50] Lower HER-2/chromosome enumeration probe 17 ratio in cytologic HER-2 fluorescence in situ hybridization for breast cancers - Three-dimensional analysis of intranuclear localization of centromere 17 and HER-2 signals
    Itoh, Hitoshi
    Miyajima, Yoko
    Umemura, Shinobu
    Osamura, Robert Y.
    CANCER CYTOPATHOLOGY, 2008, 114 (02) : 134 - 140
12345